About Molecular Devices
Molecular Devices is a company based in Sunnyvale (United States) founded in 1983 was acquired by Danaher in September 2009. Molecular Devices has completed 2 acquisitions, including Cellesce and LJL BioSystems. Molecular Devices offers products and services including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System. Molecular Devices operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Sunnyvale, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website moleculardevices.com
- Social LinkedIn X Facebook
- Acquired by Danaher (Sep 2009)
Products & Services of Molecular Devices
Molecular Devices offers a comprehensive portfolio of products and services, including SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System.
Devices for high-throughput screening in life science assays.
Software for processing data from microplate readers.
Automated system for reliable cell culture and imaging workflows.
Investors in Molecular Devices
Molecular Devices has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Danaher and mdsinc.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dental equipment and medical instruments are manufactured for therapeutic areas. | 1969 | danaher.com | - | |
- | – | mdsinc.com | - |
Investor details for Molecular Devices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Molecular Devices
33 people are tracked at Molecular Devices (2 in leadership, 31 in team).
| Name | Role | Group |
|---|---|---|
Susan Murphy | Vice President Sales And Marketing | Leadership |
Aaron Risinger | Director Of Business Development | Leadership |
Jinli Z. | Sr. Account Executive | Team |
Patrick Adden | Senior Key Account Manager | Team |
Randy M. | Drug Discovery Sales Representative | Team |
Yulong Huang | Account Executive | Team |
Nisha Pandit | Account Manager | Team |
Klaus Helm | Imagexpress Pico Account Manager, Germany & Austria | Team |
Rachel Ruschak | Inside Sales Representative | Team |
Ruth Blanco | Account Manager Key Account | Team |
Faik Nadi Okka | Key Account Manager | Team |
Amit Bhat | Business Development Manager | Team |
Byung-Jung Choi | Senior Sales Representative | Team |
Andreas Krosta | Sales Manager DACH | Team |
Kara Spofford | Senior Technical Sales Representative | Team |
Matt Mansfield | Technical Sales Representative | Team |
Mark Stephens | Account Manager | Team |
Justin J. | Sales Supervisor | Team |
Sandeep Hegde M S | Sales Manager For Karnataka & Kerala, India | Team |
Benjamin Kwong | Sales Support | Team |
13 more people are available in the full profile.
Complete people profiles for Molecular Devices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Molecular Devices
Molecular Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellesce and LJL BioSystems.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Scalable processes for organoid expansion are developed. | cellesce.com | Cardiff, United Kingdom | 2013 | Dec 2022 | •••• | |
Fluorescence detection instruments for life sciences are developed. | ljlbio.com | Sunnyvale, United States | 1988 | Aug 2000 | •••• |
Complete acquisition details for Molecular Devices
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Molecular Devices
5 dated milestones of Molecular Devices across 39 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Devices is founded.
- Acquisition Acquires LJL BioSystems.
- Exit Acquired by mdsinc.com.
- Exit Acquired by Danaher.
- Acquisition Acquires Cellesce.
Competitors of Molecular Devices
Molecular Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. | |
| merckgroup.com | 1668 | Darmstadt, Germany | – | 922 | Merck is engaged in science and technology solutions globally. | |
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| telesisbio.com | 2013 | San Diego, United States | $25M | – | Online platform offering life sciences reagents and kits | |
| bio-rad.com | 1952 | Hercules, United States | – | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | |
| siemens-healthineers.com | 1847 | Erlangen, Germany | – | 66,000 | AI-based medical diagnostics are developed for healthcare applications. | |
| apbiocode.com | 2008 | Santa Fe Springs, United States | $20.29M | 66 | Assay kits and instruments for in vitro diagnostics are developed. |
Detailed competitors of Molecular Devices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Molecular Devices
The website of Molecular Devices (moleculardevices.com) receives about 131.7K visits a month.
- Monthly visits131.7K
▲ 1.2% vs previous month
Websites whose visitors overlap most with Molecular Devices. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biotek.com | 100% | – | – | View details | |
| sutter.com | 88% | – | #1,404,750 | View details | |
| wpiinc.com | 85% | 88.5K | #439,774 | View details | |
| abyntek.com | 80% | 34.5K | #856,770 | View details | |
scincomall.com | scincomall.com | 77% | – | #2,046,519 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Molecular Devices
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Molecular Devices
Complete news archive for Molecular Devices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Molecular Devices
10 companies that operate in the same segment as Molecular Devices (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecular Devices
Molecular Devices was founded in 1983.
Molecular Devices is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Founded in 1983 and based in Sunnyvale, United States, automated solutions for life science research are offered by the company. These encompass cell culture systems, high-content imaging platforms, microplate readers, and clone screening tools. Operations focus on high-throughput screening, plate-based assays, and organoid production services, with GxP compliance support for GMPGLP laboratories. Drug discovery and cell line development are facilitated across research workflows.
Molecular Devices's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Molecular Devices offers SpectraMax Microplate Readers, SoftMax Pro Software, and CellXpress.ai Automated Cell Culture System.
Molecular Devices has made 2 acquisitions, including Cellesce, and LJL BioSystems.
Molecular Devices has 2 investors. Key investors include Danaher, and mdsinc.com.
Yes. Molecular Devices was acquired by Danaher in September 2009.
The website of Molecular Devices receives about 132 thousand visits a month.